JPS50148349A - - Google Patents

Info

Publication number
JPS50148349A
JPS50148349A JP50045924A JP4592475A JPS50148349A JP S50148349 A JPS50148349 A JP S50148349A JP 50045924 A JP50045924 A JP 50045924A JP 4592475 A JP4592475 A JP 4592475A JP S50148349 A JPS50148349 A JP S50148349A
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP50045924A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPS50148349A publication Critical patent/JPS50148349A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D331/00—Heterocyclic compounds containing rings of less than five members, having one sulfur atom as the only ring hetero atom
    • C07D331/04—Four-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/46—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings substituted on the ring sulfur atom
    • C07D333/48—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings substituted on the ring sulfur atom by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
JP50045924A 1974-04-17 1975-04-17 Pending JPS50148349A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US46169974A 1974-04-17 1974-04-17
US05/555,307 US4009847A (en) 1974-04-17 1975-03-11 1-Tertiary-alkyl-3-(substituted thienyl)ureas and 1-tertiary-alkyl-3-(substituted thietyl)ureas as antihypertensive agents

Publications (1)

Publication Number Publication Date
JPS50148349A true JPS50148349A (ja) 1975-11-27

Family

ID=27040095

Family Applications (1)

Application Number Title Priority Date Filing Date
JP50045924A Pending JPS50148349A (ja) 1974-04-17 1975-04-17

Country Status (21)

Country Link
US (1) US4009847A (ja)
JP (1) JPS50148349A (ja)
AR (1) AR208545A1 (ja)
CA (1) CA1047042A (ja)
CH (1) CH611292A5 (ja)
DD (1) DD117223A5 (ja)
DE (1) DE2516554A1 (ja)
DK (1) DK164175A (ja)
ES (1) ES436648A1 (ja)
FI (1) FI751128A (ja)
FR (1) FR2267773B1 (ja)
GB (1) GB1461209A (ja)
HU (1) HU173052B (ja)
IE (1) IE41143B1 (ja)
IL (1) IL47095A (ja)
LU (1) LU72306A1 (ja)
NL (1) NL7504570A (ja)
NO (1) NO144071C (ja)
PH (1) PH11722A (ja)
SE (1) SE417965B (ja)
YU (1) YU96075A (ja)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4156738A (en) * 1977-10-07 1979-05-29 E. I. Du Pont De Nemours And Company Ureidonitriles useful as antihypertensives
US6344476B1 (en) 1997-05-23 2002-02-05 Bayer Corporation Inhibition of p38 kinase activity by aryl ureas
US6187799B1 (en) * 1997-05-23 2001-02-13 Onyx Pharmaceuticals Inhibition of raf kinase activity using aryl ureas
US20080300281A1 (en) * 1997-12-22 2008-12-04 Jacques Dumas Inhibition of p38 Kinase Activity Using Aryl and Heteroaryl Substituted Heterocyclic Ureas
US7517880B2 (en) * 1997-12-22 2009-04-14 Bayer Pharmaceuticals Corporation Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureas
US7329670B1 (en) * 1997-12-22 2008-02-12 Bayer Pharmaceuticals Corporation Inhibition of RAF kinase using aryl and heteroaryl substituted heterocyclic ureas
US20080269265A1 (en) * 1998-12-22 2008-10-30 Scott Miller Inhibition Of Raf Kinase Using Symmetrical And Unsymmetrical Substituted Diphenyl Ureas
ATE556713T1 (de) * 1999-01-13 2012-05-15 Bayer Healthcare Llc Omega-carboxyarylsubstituierte-diphenyl- harnstoffe als p38-kinasehemmer
EP1140840B1 (en) 1999-01-13 2006-03-22 Bayer Pharmaceuticals Corp. -g(v)-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
US8124630B2 (en) 1999-01-13 2012-02-28 Bayer Healthcare Llc ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
ME00275B (me) * 1999-01-13 2011-02-10 Bayer Corp ω-KARBOKSIARIL SUPSTITUISANI DIFENIL KARBAMIDI KAO INHIBITORI RAF KINAZE
US7928239B2 (en) 1999-01-13 2011-04-19 Bayer Healthcare Llc Inhibition of RAF kinase using quinolyl, isoquinolyl or pyridyl ureas
US7235576B1 (en) 2001-01-12 2007-06-26 Bayer Pharmaceuticals Corporation Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
US7371763B2 (en) * 2001-04-20 2008-05-13 Bayer Pharmaceuticals Corporation Inhibition of raf kinase using quinolyl, isoquinolyl or pyridyl ureas
SI1450799T1 (sl) * 2001-12-03 2007-02-28 Bayer Pharmaceuticals Corp Aril secninske spojine v kombinaciji z drugimi citostaticnimi ali citotoksicnimi sredstvi za zdravljenje cloveskih rakov
US20080108672A1 (en) * 2002-01-11 2008-05-08 Bernd Riedl Omega-Carboxyaryl Substituted Diphenyl Ureas As Raf Kinase Inhibitors
ATE529406T1 (de) 2002-02-11 2011-11-15 Bayer Healthcare Llc Aryl-harnstoffe als kinase inhibitoren
AU2003209116A1 (en) * 2002-02-11 2003-09-04 Bayer Pharmaceuticals Corporation Aryl ureas with angiogenesis inhibiting activity
WO2003068223A1 (en) * 2002-02-11 2003-08-21 Bayer Corporation Aryl ureas with raf kinase and angiogenesis inhibiting activity
AU2003209119A1 (en) * 2002-02-11 2003-09-04 Bayer Pharmaceuticals Corporation Pyridine, quinoline, and isoquinoline n-oxides as kinase inhibitors
US7557129B2 (en) 2003-02-28 2009-07-07 Bayer Healthcare Llc Cyanopyridine derivatives useful in the treatment of cancer and other disorders
JP4860474B2 (ja) * 2003-05-20 2012-01-25 バイエル、ファーマシューテイカルズ、コーポレイション Ｐｄｇｆｒによって仲介される病気のためのジアリール尿素
DK1663978T3 (da) * 2003-07-23 2008-04-07 Bayer Pharmaceuticals Corp Fluorsubstitueret omega-carboxyaryl-diphenylurinstof til behandling og forebyggelse af sygdomme og lidelser
WO2005110994A2 (en) * 2004-04-30 2005-11-24 Bayer Pharmaceuticals Corporation Substituted pyrazolyl urea derivatives useful in the treatment of cancer

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH452475A (de) * 1965-05-20 1968-05-31 Bayer Ag Verfahren zum Färben und Bedrucken von synthetischem Textilmaterial mit Anthrachinonfarbstoffen

Also Published As

Publication number Publication date
CA1047042A (en) 1979-01-23
DD117223A5 (ja) 1976-01-05
CH611292A5 (ja) 1979-05-31
DK164175A (da) 1975-10-18
FR2267773B1 (ja) 1978-08-18
AR208545A1 (es) 1977-02-15
FR2267773A1 (ja) 1975-11-14
SE417965B (sv) 1981-04-27
IL47095A0 (en) 1975-06-25
NL7504570A (nl) 1975-10-21
FI751128A (ja) 1975-10-18
SE7503523L (sv) 1975-10-20
HU173052B (hu) 1979-02-28
DE2516554A1 (de) 1975-10-30
IE41143B1 (en) 1979-10-24
PH11722A (en) 1978-05-30
LU72306A1 (ja) 1976-03-17
NO751351L (ja) 1975-10-20
GB1461209A (en) 1977-01-13
AU8013575A (en) 1976-10-21
NO144071C (no) 1981-06-17
IL47095A (en) 1978-03-10
IE41143L (en) 1975-10-17
NO144071B (no) 1981-03-09
YU96075A (en) 1983-04-27
ES436648A1 (es) 1977-08-01
US4009847A (en) 1977-03-01

Similar Documents

Publication Publication Date Title
FR2293835B1 (ja)
DK97875A (ja)
FR2269369A1 (ja)
JPS50107269A (ja)
DE2406102B2 (ja)
JPS50128293A (ja)
FR2290349B2 (ja)
FR2263575B1 (ja)
JPS50110488U (ja)
CS170719B1 (ja)
DK158475A (ja)
CH576222A5 (ja)
CH574162A5 (ja)
CH579884A5 (ja)
CH579822A5 (ja)
CH579399A5 (ja)
CH579333A5 (ja)
CH578788A5 (ja)
CH578712A5 (ja)
CH578659A5 (ja)
CH578204B5 (ja)
CH577763A5 (ja)
CH577679A5 (ja)
CH576666B5 (ja)
CH1378974A4 (ja)